Twin Tree Management’s Astrana Health ASTH Stock Holding History

Twin Tree Management’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-342	Closed	-$6K	–	1513
2019 Q3	$6K	Buy	+342	New	+$5.85K	﹤0.01%	1157

Other funds holding ASTH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Manchester Financial Westlake Village, California $563M AUM 21.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Twin Tree Management's ASTH Position: Q4 2019 in Review

Twin Tree Management sold out of Astrana Health (ASTH) in Q4 2019, closing a stake of 342 shares — an estimated $6K sold.

Twin Tree Management first reported a position in ASTH in Q3 2019 and held it in 1 quarter. The position peaked at $6K in Q3 2019. 54 funds tracked by Wall St. Rank hold ASTH as of Q4 2019.

Twin Tree Management reported no remaining Astrana Health position as of Q4 2019 after selling out during the quarter.
Twin Tree Management sold 342 Astrana Health shares in Q4 2019, an estimated $6K.
Twin Tree Management first reported a position in Astrana Health in Q3 2019 and held it in 1 quarter.
Twin Tree Management's Astrana Health position peaked at $6K in Q3 2019.
54 funds tracked by Wall St. Rank held Astrana Health as of Q4 2019.

Based on Twin Tree Management's 13F filing for Q4 2019, filed 14 Feb 2020.